All In Biotech

Drug Trial Radar · NCT00980980

Cluster Randomized Trial of Hospitals to Assess Impact of Targeted Versus Universal Strategies to Reduce Methicillin-resistant Staphylococcus Aureus (MRSA) in Intensive Care Units (ICUs)

Cluster Randomized Trial of Hospitals to Assess Impact of Targeted Versus Universal

Last checked: Nov 19, 2026Latest source record: May 2, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 74,256 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

74,256

Actual

Start

Sep 2009

Primary completion

Sep 2011

Study completion Sep 2011

Sponsor

Lead sponsor
Harvard Pilgrim Health CareAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Agency for Healthcare Research and Quality (AHRQ); Centers for Disease Control and Prevention; Hospital Corporation of America; University of California, Irvine; Department of Population Medicine, Harvard Medical School / Harvard Pilgrim Healthcare Institute
First posted
Sep 21, 2009

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Primary purpose
Prevention
Who can join
All sexes, from 13 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The Randomized Evaluation of Decolonization versus Universal Clearance to Eliminate MRSA (REDUCE MRSA) Trial is a cluster randomized trial of the comparative effectiveness of three strategies to prevent methicillin-resistant Staphylococcus aureus (MRSA) in intensive care units. The three strategies to be evaluated are: * screening on admission followed by isolation of MRSA+ patients * screening on admission followed by isolation and decolonization of MRSA+ patients * universal decolonization on admission with no screening. The decolonization regimen involves bathing with chlorhexidine plus intra-nasal application of mupirocin. The main outcome will be MRSA+ clinical cultures. The study is a partnership between the CDC, the CDC Prevention Epicenters, and the Hospital Corporation of America.

Conditions

  • Methicillin-resistant Staphylococcus Aureus

Interventions

  • Chlorhexidine bath and nasal mupirocinDrug

    The intervention / decolonization regimen will consist of the most commonly used topical regimen in the US - a combination of daily baths with 2% chlorhexidine cloths , plus 5 days of topical intranasal mupirocin ointment (bilateral nares, twice daily)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Main Outcome: Patients With Nosocomial MRSA Clinical CulturesTime frame: The 30-month time frame represents 12-month baseline and 18-month intervention periods. During these time periods, outcomes are defined as events occurring during attributed ICU time: from day 3 of the ICU stay until 2 days after ICU discharge.

Locations

42 sites in 1 country. Site status is shown where the registry gives one.

  • Alaska Regional

    Anchorage, Alaska

  • Los Robles Hosp & Med Ctr

    Thousand Oaks, California

  • The Medical Center of Aurora

    Aurora, Colorado

  • Blake Medical Center

    Brandenton, Florida

  • Brandon Hospital

    Brandon, Florida

  • Columbia Hosp Corp S Broward (Westside)

    Fort Lauderdale, Florida

  • Palms West Hospital

    Fort Lauderdale, Florida

  • Plantation General

    Fort Lauderdale, Florida

  • Regional Med Cr Bayonet Point

    Hudson, Florida

  • Largo Medical Center

    Largo, Florida

  • Community Hospital

    New Port Richey, Florida

  • Orange Park Med Ctr

    Orange Park, Florida

  • Fawcett Memorial Hospital

    Port Charlotte, Florida

  • Doctors Hospital of Sarasota

    Sarasota, Florida

  • South Bay Hospital

    Sun City Center, Florida

  • Capital Regional Med Ctr

    Tallahassee, Florida

  • Coliseum (Macon) Northside

    Macon, Georgia

  • Coliseum Medical Center

    Macon, Georgia

  • Cartersville Medical Center

    Tucker, Georgia

  • Eastern Idaho Reg Med Ctr

    Idaho Falls, Idaho

  • Garden Park Medical Center

    Gulfport, Mississippi

  • Lee's Summit Medical Center

    Kansas City, Missouri

  • Menorah Medical Center

    Kansas City, Missouri

  • Overland Park Regional Hospital

    Kansas City, Missouri

  • Research Belton Hospital

    Kansas City, Missouri

  • Moutainview Medical Center

    Las Vegas, Nevada

  • Parkland Medical Center

    Derry, New Hampshire

  • Oklahoma University Medical Center

    Oklahoma City, Oklahoma

  • Grand Strand Regional Medical Center

    Myrtle Beach, South Carolina

  • Parkridge Medical Center

    Chattanooga, Tennessee

  • Centennial Medical Center

    Nashville, Tennessee

  • Stonecrest

    Smyrna, Tennessee

  • St. David's Medical Center

    Austin, Texas

  • Del Sol Medical Center

    El Paso, Texas

  • Las Palmas Medical Center

    El Paso, Texas

  • Medical Center of Plano

    Plano, Texas

  • Methodist Hospital

    San Antonio, Texas

  • Clear Lake Regional

    Webster, Texas

  • Montgomery Regional Hospital

    Blacksburg, Virginia

  • Columbia Alleghany Regional Hospital

    Low Moor, Virginia

Showing 40 of 42 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.